A Phase III, Multi-center, Randomized Trial of Pemetrexed and Gefitinib in Never-smoker and Adenocarcinoma Patients With Non-small Cell Lung Cancer Previously Treated With Platinum-based Chemotherapy.

Trial Profile

A Phase III, Multi-center, Randomized Trial of Pemetrexed and Gefitinib in Never-smoker and Adenocarcinoma Patients With Non-small Cell Lung Cancer Previously Treated With Platinum-based Chemotherapy.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2012

At a glance

  • Drugs Gefitinib (Primary) ; Pemetrexed (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jul 2011 Status changed from recruiting to active, no longer recruiting.
    • 07 Jul 2011 Results presented at the 14th World Conference on Lung Cancer.
    • 07 Jun 2011 Actual patient number (n=135) reported at the American Society of Clinical Oncology Annual Meeting 2011. Additional identifier also reported (KCSG-LU08-01).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top